- Home
- ZCMD vs CRIS Comparison
ZCMD vs CRIS Comparison
Compare ZCMD & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZCMD
- CRIS
- Stock Information
- Founded
- ZCMD 2012
- CRIS 2000
- Country
- ZCMD China
- CRIS United States
- Employees
- ZCMD N/A
- CRIS N/A
- Industry
- ZCMD Other Consumer Services
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZCMD Real Estate
- CRIS Health Care
- Exchange
- ZCMD Nasdaq
- CRIS Nasdaq
- Market Cap
- ZCMD 29.0M
- CRIS 21.3M
- IPO Year
- ZCMD 2020
- CRIS 2000
- Fundamental
- Price
- ZCMD $1.14
- CRIS $1.88
- Analyst Decision
- ZCMD
- CRIS Strong Buy
- Analyst Count
- ZCMD 0
- CRIS 2
- Target Price
- ZCMD N/A
- CRIS $16.50
- AVG Volume (30 Days)
- ZCMD 506.1K
- CRIS 172.7K
- Earning Date
- ZCMD 01-01-0001
- CRIS 07-31-2025
- Dividend Yield
- ZCMD N/A
- CRIS N/A
- EPS Growth
- ZCMD N/A
- CRIS N/A
- EPS
- ZCMD N/A
- CRIS N/A
- Revenue
- ZCMD $15,864,773.00
- CRIS $11,202,000.00
- Revenue This Year
- ZCMD N/A
- CRIS N/A
- Revenue Next Year
- ZCMD N/A
- CRIS $10.67
- P/E Ratio
- ZCMD N/A
- CRIS N/A
- Revenue Growth
- ZCMD N/A
- CRIS 14.17
- 52 Week Low
- ZCMD $0.95
- CRIS $1.02
- 52 Week High
- ZCMD $2.97
- CRIS $8.29
- Technical
- Relative Strength Index (RSI)
- ZCMD 48.00
- CRIS 42.69
- Support Level
- ZCMD $1.13
- CRIS $1.70
- Resistance Level
- ZCMD $1.24
- CRIS $2.01
- Average True Range (ATR)
- ZCMD 0.11
- CRIS 0.21
- MACD
- ZCMD -0.01
- CRIS -0.03
- Stochastic Oscillator
- ZCMD 21.84
- CRIS 38.78
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.